DIEGO SANTA ANA: Open Payments
NPI 1003308610 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $347 |
| AstraZeneca Pharmaceuticals LP | 3 | $210 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Astellas Pharma US Inc | 1 | $31 |
| BETA BIONICS, INC. | 1 | $26 |
| Exact Sciences Corporation | 1 | $21 |
| Seqirus USA Inc | 1 | $16 |
Products named: Wegovy, BREZTRI, Kerendia, AIRSUPRA, Rybelsus, JARDIANCE, Veozah, iLet Bionic Pancreas.
Industry payments across TX — which companies pay providers there.
